Drugmaker Johnson and Johnson is suing the Department of Health and Human Services and the Health Resources and Services Administration for blocking its new 340B rebate model, and is seeking to verify ...
Wolfe Research analyst Alexandria Hammond initiated coverage of Johnson & Johnson with an Outperform rating and $190 price target ...
Johnson & Johnson MedTech has entered into an exclusive commercial distribution agreement with Responsive Arthroscopy, a medical device company specializing in sports soft tissue repair solutions. The ...
The jury specifically found that the J&J entities failed to warn and that their conduct caused Mr. Plotkin’s injury. On October 15, the jury awarded $15 million in damages to plaintiffs. The jury ...
Johnson & Johnson sued the U.S. Health and Human Services Department on Tuesday, accusing the agency of blocking its plan to ...
HRSA said it had no comments in response to the lawsuit. Arnold & Porter Kaye Scholer LLP represents J&J. The case is Johnson ...
With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the ...
WASHINGTON — As Speaker Mike Johnson marks one year on the job Friday, he’s fighting hard to preserve House Republicans’ razor-thin majority — and his speakership. Multiple House ...
ONL Therapeutics Inc. is a classic case of a University of Michigan spinout. The Ann Arbor biotechnology startup netted the largest VC deal in the state in Q3, closing an oversubscribed $65 million ...
Speaker Mike Johnson (R-La.) is disputing Democrats’ assertion that he wants to repeal ObamaCare after Vice President Harris’s campaign seized on comments he made at a campaign stop this week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback